跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 94 条关于
“Recordati S.p.A.”
全部
94
临床试验
10
药物
4
机构
24
资讯
56
8个月前
Amarin Reports Strong Q4 2025 Performance as VASCEPA/VAZKEPA Franchise Positioned to Benefit from Emerging Triglyceride Therapies
5个月前
CVC Capital Proposes €10.9 Billion Takeover of Italian Pharma Recordati
去年
Recordati Acquires Global Rights to Sanofi's CAD Treatment Enjaymo in $825M Deal
去年
Recordati Secures Exclusive European Rights to Cardiovascular Drug Vazkepa in $175 Million Deal with Amarin
10个月前
Recordati Rare Diseases Presents Nine Research Studies on Rare Hematologic Disorders at ASH 2025
9个月前
Recordati Presents Breakthrough AI Technology and Real-World Evidence for Castleman Disease at ASH 2025
去年
Recordati's Isturisa Approved in South Korea for Cushing's Disease
9个月前
Real-World Safety Data Confirms Long-Term Tolerability of ENJAYMO in Cold Agglutinin Disease Patients
去年
FDA Approves Osilodrostat for Second-Line Cushing Syndrome Treatment as Pipeline Advances
3个月前
Stevanato Group Shareholders Approve All Resolutions at 2026 Annual Meeting, Including Dividend and Board Appointments
第 1 页,共 6 页
上一页
下一页